A next-generation proteolysis-targeting vaccine approach (PROTAR vaccine 2.0) was developed that attenuated influenza viruses by degrading multiple viral proteins and showed promising safety and efficacy in animal models with viral challenge.
- Chunhe Zhang
- Jihuan Hou
- Longlong Si
